본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP.
()

Chae Hee Jung
(Branch of Hemato Oncology)
. Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP.. LEUKEMIA & LYMPHOMA. 2020-01-06; 2020; Online:Published. IF 2.969 (2019)
Comparison of underwater endoscopic mucosal resection and endoscopic submucosal dissection of rectal neuroendocrine tumor (with video) Han Kyung Su
(Department of Surgery)

Park Sung Sil
(Department of Surgery)
. Comparison of underwater endoscopic mucosal resection and endoscopic submucosal dissection of rectal neuroendocrine tumor (with video). GASTROINTESTINAL ENDOSCOPY. 2020-01-03; 2020; 91(5):1164~1171. IF 6.89 (2019)
Urinary Bisphenol A and its analogues and haemato-biochemical alterations of pregnant women in Korea Kim Byung Mi
(Division of Cancer Registration & Surveillance)

Kang So Ra
(Division of Cancer Prevention)
. Urinary Bisphenol A and its analogues and haemato-biochemical alterations of pregnant women in Korea. ENVIRONMENTAL RESEARCH. 2020-01-03; 2020; 182:109104~. IF 5.715 (2019)
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma Hyeon-Seok Eom
(Branch of Hemato Oncology)

Lee, Hyewon
(Branch of Hemato Oncology)
. A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma. ANNALS OF HEMATOLOGY. 2020-01-02; 2020; 99(2):255~264. IF 2.904 (2019)
Reducing the Model Variance of a Rectal Cancer Segmentation Network Sohn Dae Kyung
(Division of Convergence Technology)

LEE JOO HYUNG
(Division of Convergence Technology)
. Reducing the Model Variance of a Rectal Cancer Segmentation Network. IEEE Access. 2019-12-31; 2019; 7:182725~182733. IF 4.098 (2018)
Comparison of ABO isoagglutinin titres by three different methods:tube haemagglutination, micro-column agglutination and agutomated immunohematology analyzer based on erythrocyte-magnetized technology Sun-Young Kong
(Division of Translational Science)

Shim Hyoeun
(Department of Laboratory Medicine)
. Comparison of ABO isoagglutinin titres by three different methods:tube haemagglutination, micro-column agglutination and agutomated immunohematology analyzer based on erythrocyte-magnetized technology. Vox Sanguinis. 2019-12-26; 2019; 115(3):233~240. IF 2.364 (2018)
Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis Choi Beom-Kyu
(Biomedicine Production Branch)

ROHIT SINGH
(Division of Tomor Immunology)
. Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis. eLife. 2019-12-24; 2019; 8:e48916~e48916. IF 7.551 (2018)
Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease
()

Cho Yu Ri
(Division of Clinical Research)
. Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease. HEPATOLOGY INTERNATIONAL. 2019-12-19; 2020; 14(2):270~280. IF 5.102 (2019)
Randomized controlled trial of advance care planning video decision aid for the general population
()

Kang EunKyo
(Division of Cancer Early Detection)
. Randomized controlled trial of advance care planning video decision aid for the general population. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2019-12-19; 2020; 59(6):1239~1247. IF 3.378 (2018)
FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures Hong, Dong Wan
(Bioinformatics Analysis Team)

Kim Hyun bin
(Bioinformatics Analysis Team)
. FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures. genome medicine. 2019-12-17; 2019; Online:Published. IF 10.886 (2018)
First page Prev paging 131 132 133 134 135 136 137 138 139 140 next paging last page